Evidence map›Paper›PMID 31315675›Full record

ArticleActa neuropathologica communications2019

Retinal pathology in experimental optic neuritis is characterized by retrograde degeneration and gliosis.

Praveena Manogaran, Marijana Samardzija, Anaïs Nura Schad, Carla Andrea Wicki, Christine Walker-Egger, Markus Rudin, Christian Grimm, Sven Schippling

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. MOGJournal of neuroinflammation · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Praveena ManogaranDepartment of Information Technology and Electrical Engineering, Swiss Federal Institute of Technology, Zurich, Switzerland. pmanogar@student.ethz.ch.ORCID 0000-0003-0829-7171
Marijana SamardzijaDepartment of Ophthalmology, Lab for Retinal Cell Biology, University of Zurich, Zurich, Switzerland.
Anaïs Nura SchadDepartment of Biology, University of Zurich, Zurich, Switzerland.
Carla Andrea WickiNeuroimmunology and Multiple Sclerosis Research, Clinic for Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Christine Walker-EggerNeuroimmunology and Multiple Sclerosis Research, Clinic for Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Markus RudinDepartment of Information Technology and Electrical Engineering, Swiss Federal Institute of Technology, Zurich, Switzerland.
Christian GrimmDepartment of Ophthalmology, Lab for Retinal Cell Biology, University of Zurich, Zurich, Switzerland.
Sven SchipplingNeuroimmunology and Multiple Sclerosis Research, Clinic for Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
University of Zurich · CH

Funding

Swiss National Science Foundation 320030_175770
6 · The paper itself

Abstract

The exact mechanisms and temporal sequence of neurodegeneration in multiple sclerosis are still unresolved. The visual pathway including its unmyelinated retinal axons, can serve as a prototypic model of neurodegeneration in experimental optic neuritis. We conducted a longitudinal study combining retinal imaging through optical coherence tomography (OCT) with immunohistochemical analyses of retinal and optic nerve tissue at various time points in experimental autoimmune encephalomyelitis (EAE).Inner retinal layer (IRL) thickness was measured in 30 EAE and 14 healthy control C57BL/6 J mice using OCT. Distribution of marker proteins was assessed by immunofluorescence staining and retinal mRNA levels were assayed using real-time PCR. Histological morphology was evaluated on light and electron microscopy images.Signs of inflammatory edema 11 days post immunisation coincided with IRL thickening, while neuro-axonal degeneration throughout the disease course contributed to IRL thinning observed after 20 days post immunisation. Retinal pathology, including axonal transport impairment, was observed early, prior to cellular infiltration (i.e. T-cells) in the optic nerve 11 days post immunisation. Yet, the effects of early retinal damage on OCT-derived readouts were outweighed by the initial inflammatory edema. Early microglial activation and astrocytosis was detected in the retina prior to retinal ganglion cell loss and persisted until 33 days post immunisation. Müller cell reactivity (i.e. aquaporin-4 and glutamine synthetase decrease) presented after 11 days post immunisation in the IRL. Severe neuro-axonal degeneration was observed in the optic nerve and retina until 33 days post immunisation.Initial signs of retinal pathology subsequent to early glial activity, suggests a need for prophylactic treatment of optic neuritis. Following early inflammation, Müller cells possibly respond to retinal pathology with compensatory mechanisms. Although the majority of the IRL damage observed is likely due to retrograde degeneration following optic neuritis, initial pathology, possibly due to gliosis, may contribute further to IRL thinning. These results add morphological substrate to our OCT findings. The extent and rapid onset of axonal and neuronal damage in this model appears relevant for testing interventions scaled to human optic neuritis.

Indexed as

AnimalsEncephalomyelitis, Autoimmune, ExperimentalFemaleGliosisMiceMice, Inbred C57BLOptic NeuritisRetinaRetrograde DegenerationTomography, Optical CoherenceExperimental autoimmune encephalomyelitisGliosisNeuro-axonal degenerationOptical coherence tomographyOptic neuritisRetina

Identifiers

PMID31315675
PMCPMC6637505
OpenAlexW2957170417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.